会计年度:2021-12-31收入分布
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 合计 | 15,695,664,147.00 | 10,652,636,694.00 | 5,043,027,453.00 | 32.13 |
| 加盟、联盟及分销 | 1,785,420,762.00 | 1,575,088,485.00 | 210,332,277.00 | 11.78 |
| 零售 | 13,790,878,557.00 | 9,001,823,921.00 | 4,789,054,636.00 | 34.73 |
| 其他 | 119,364,828.00 | 75,724,288.00 | 43,640,540.00 | 36.56 |
|
会计年度:2021-06-30
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 合计 | 7,460,708,649.00 | 4,968,508,435.00 | 2,492,200,214.00 | 33.40 |
| 其他(补充) | 53,476,988.00 | 36,752,083.00 | 16,724,905.00 | 31.27 |
| 医药零售 | 6,341,253,060.00 | 4,009,899,811.00 | 2,331,353,249.00 | 36.76 |
| 医药批发 | 1,065,978,601.00 | 921,856,541.00 | 144,122,060.00 | 13.52 |
|
会计年度:2020-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 合计 | 13,966,699,240.00 | 9,488,810,558.00 | 4,477,888,682.00 | 32.06 |
| 加盟、联盟及分销 | 1,785,148,786.00 | 1,569,687,988.00 | 215,460,798.00 | 12.07 |
| 零售 | 12,079,741,240.00 | 7,833,351,654.00 | 4,246,389,586.00 | 35.15 |
| 其他 | 101,809,214.00 | 85,770,916.00 | 16,038,298.00 | 15.75 |
|
会计年度:2020-06-30
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 合计 | 6,686,530,796.00 | 4,525,896,368.00 | 2,160,634,428.00 | 32.31 |
| 其他 | 57,738,510.00 | 53,077,118.00 | 4,661,392.00 | 8.07 |
| 医药零售 | 5,661,119,085.00 | 3,609,657,835.00 | 2,051,461,250.00 | 36.24 |
| 医药批发 | 967,613,201.00 | 863,161,415.00 | 104,451,786.00 | 10.79 |
|
会计年度:2019-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 合计 | 11,663,176,229.00 | 7,745,503,599.00 | 3,917,672,630.00 | 33.59 |
| 其他 | 84,063,383.00 | 63,002,991.00 | 21,060,392.00 | 25.05 |
| 医药零售 | 10,289,149,581.00 | 6,551,833,390.00 | 3,737,316,191.00 | 36.32 |
| 医药批发 | 1,289,963,265.00 | 1,130,667,218.00 | 159,296,047.00 | 12.35 |
|
1/3 转到 
